Regulating the intestinal immune system

Regulating the intestinal immune system" is not a specific molecule, receptor, or defined therapeutic target but rather a **broad physiological concept** describing the integrated activities of multiple cell types, signaling molecules, pathways, and environmental factors involved in maintaining immune homeostasis within the gut. Key elements in the regulation of the intestinal immune system include **intestinal epithelial cells** (IECs), which produce cytokines and antimicrobial peptides and express various **pattern recognition receptors** (such as Toll-like receptors, NOD-like receptors, and others)[1][3]; **regulatory T cells** (Tregs), which exert immune-suppressive functions via cytokines like IL-10 and TGF-β[2][5]; **dendritic cells** and innate lymphoid cells, which help shape the immune landscape; and regulatory pathways involving the **intestinal mucosal barrier**, the microbiome, and dietary/metabolic signals[3][5][6]. Disruption to these regulatory networks can contribute to intestinal inflammation, infection, autoimmunity, and diseases like IBD[2][4]. While many **drugs and interventions** aim to restore or modulate intestinal immune regulation, "regulating the intestinal immune system" does not refer to a single druggable entity or biomarker. Therefore, it should not be listed as a therapeutic target in a structured database, and entries for this term should be curated or redirected to specific molecular targets, cell types, or signaling pathways.